Pacific Biosciences of California, Inc. Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
Pacific Biosciences of California, Inc. (PACB) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of $120.20 million for the 12-month period ending 2024-12-31, per its 10-K filed 2026-02-25.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2026-02-25
- Pacific Biosciences of California, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2024 was $120.20M.
- Pacific Biosciences of California, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2017 was $249.20M, a 21.49% decline from fiscal 2016.
- Pacific Biosciences of California, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2016 was $317.40M, a 11.13% increase from fiscal 2015.
- Pacific Biosciences of California, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2015 was $285.60M, a 4.39% increase from fiscal 2014.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month as first filed |
|---|---|---|
| 2024-12-31 | $120.20M 10-K · filed 2026-02-25 | |
| 2017-12-31 | $249.20M 10-K · filed 2018-02-26 | |
| 2016-12-31 | $317.40M 10-K · filed 2018-02-26 | |
| 2015-12-31 | $285.60M 10-K · filed 2017-03-06 | |
| 2014-12-31 | $273.60M 10-K · filed 2016-03-11 | $27.40M 10-K · filed 2015-03-12 |
| 2013-12-31 | $31.90M 10-K · filed 2015-03-12 | |
| 2012-12-31 | $33.50M 10-K · filed 2014-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |